Annexon

$23.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-0.86%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Annexon and other stocks, options, and ETFs commission-free!

About ANNX

Annexon, Inc. Common Stock, also called Annexon, is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain.

CEO
Douglas Love
Employees
48
Headquarters
South San Francisco, California
Founded
2011
Market Cap
865.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
142.26K
High Today
$24.52
Low Today
$22.49
Open Price
$23.55
Volume
82.12K
52 Week High
$38.01
52 Week Low
$15.33

ANNX Earnings

-$28.87
-$19.25
-$9.62
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

MAURY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure